GGrantIndex
Sort

40,608 grants matching prostate cancer

Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer

$497,496
Stephen K. Van Den Eeden · Kaiser Foundation Research Institute · RC1 · FY2010 · CA

Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance

$497,437
Hui-Kuan Lin · Wake Forest University Health Sciences · R01 · FY2022 · CA

A Personalized Digital Outreach Intervention for Lung Cancer Screening

$497,435
David P Miller · Wake Forest University Health Sciences · R01 · FY2024 · CA

Improving breast ultrasound specificity through SFRP2 targeted molecular imaging

$497,391
Paul A Dayton · Univ Of North Carolina Chapel Hill · U01 · FY2015 · CA

A novel strategy to overcome drug resistance in cancer

$497,379
Aimee L Edinger · University Of California-Irvine · R01 · FY2021 · CA

Enhancement of tumor radiation response by ultrasound-driven nanobubble stimulation

$497,377
Agata A Exner · Case Western Reserve University · R01 · FY2021 · CA

eHealth Activity among African American and White Cancer Survivors

$497,342
Hayley S. Thompson · Wayne State University · R01 · FY2015 · HS

BIOMARKER VALIDATION LABORATORIES

$497,252
University Of Alabama At Birmingham · U24 · FY2000 · CA

Personalized Immunotherapy of Patients with Ovarian Cancer

$497,223
Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA

Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach

$497,160
Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2023 · CA

Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody

$497,137
Paul Mathew · Tufts Medical Center · R01 · FY2024 · CA

Elucidating the Role of Tryptophan Hydroxylase 1 in Neuroendocrine Prostate Cancer

$497,109
Boyang Wu · Washington State University · R01 · FY2024 · CA

Probe Optimization for Prostate Cancer Detection

$497,070
Clifford Berkman · Washington State University · R01 · FY2010 · CA

Use of Geographic Variations to Estimate Effectiveness with Non-Randomized Data

$497,059
Mary Beth Landrum · Harvard Medical School · R01 · FY2010 · CA

MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM

$497,024
Mobile Infirmary Medical Center · U10 · FY2002 · CA

Mining Internet Conversation For Evidence Of Herbal Association

$496,998
John H Holmes · University Of Pennsylvania · RC1 · FY2010 · LM

High Intensity Ultrasound for Prostate Treatment

$496,969
Interscience Research, Inc. · R44 · FY2003 · CA

Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues

$496,959
Gabriel Popescu · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA

Molecular Dissection of Benign Prostatic Hyperplasia

$496,922
Brigham And Women'S Hospital · U01 · FY2004 · AG

Mechanism-based Classification and Targeting of Castration-Resistant Prostate Can

$496,917
Peter S Nelson · Fred Hutchinson Cancer Research Center · RC1 · FY2010 · CA

IDENTIFICATION OF CIRCULATING MICRORNAS THAT PROMOTE METASTASIS TO BONE IN PROSTATE CANCER: NOVEL EARLY DETECTION BIOMARKERS AND POTENTIAL THERAPEUTI

$496,665
University Of Vermont & State Agricultural College · · FY2014 · Department of Defense

MULTIVALENT PEPTIDOMIMETIC CONJUGATES AS INHIBITORS OF ANDROGEN RECEPTOR FUNCTION IN THERAPY-RESISTANT PROSTATE CANCER

$496,662
New York University · · FY2015 · Department of Defense

Harvard Education Program in Cancer Prevention Control (R25T)

$496,653
Glorian C Sorensen · Harvard School Of Public Health · R25 · FY2007 · CA

Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis

$496,626
Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2019 · CA

PROSTATE CANCER IN MEXICANS AMERICANS &AFRICAN AMERICAN

$496,625
University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA